BiotechTube

Budesonide + Placebo

Phase 3Completed
0 watching 0 views this week📈 Rising
72
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Proctitis

Conditions

Proctitis, Proctosigmoiditis

Trial Timeline

Nov 20, 2009 → Mar 18, 2013

NCT ID
NCT01008423

About Budesonide + Placebo

Budesonide + Placebo is a phase 3 stage product being developed by Bausch Health for Proctitis. The current trial status is completed. This product is registered under clinical trial identifier NCT01008423. Target conditions include Proctitis, Proctosigmoiditis.

Hype Score Breakdown

Clinical
27
Activity
18
Company
5
Novelty
9
Community
10

Clinical Trials (2)

NCT IDPhaseStatus
NCT01008423Phase 3Completed
NCT01008410Phase 3Completed

Competing Products

3 competing products in Proctitis

See all competitors
ProductCompanyStageHype Score
Mesalamine + Canasa + PlaceboSandoz GroupPhase 3
74
Budesonide FoamBausch HealthPhase 3
72
Budesonide + PlaceboBausch HealthPhase 3
72

Other Products from Bausch Health

nabiloneApproved
80
High dose budesonide rectal foam + Low dose budesonide rectal foam + Matching placebo rectal foamApproved
80
benzoyl peroxide wash + Tretinoin gelApproved
80
Adapalene Gel + Tretinoin GelApproved
80
Omeprazole/sodium bicarbonateApproved
80